
Validea’s guru fundamental report ranks Amazon (AMZN) highest of its 22 models under the P/E/Growth Investor (Peter Lynch) framework, awarding a 91% score—signaling strong interest—because the shares trade at a reasonable price relative to earnings growth and exhibit a sound balance sheet. The stock passes the model’s P/E/growth, sales-to-P/E, EPS growth and total debt/equity tests, while free cash flow and net cash position are rated neutral. The conclusion: Amazon looks attractive to growth-at-a-reasonable-price investors per Lynch’s criteria, but the neutral FCF and cash metrics warrant monitoring despite otherwise favorable fundamentals and valuation.
Validea’s guru fundamental report ranks Amazon.com Inc. (AMZN) highest among its 22 models using the Peter Lynch P/E/Growth Investor framework, assigning a 91% score that the publisher characterizes as "strong interest." The firm cites that AMZN trades at a reasonable price relative to earnings growth and benefits from a sound balance sheet; Validea classifies the company as a large-cap growth stock in the Retail (Specialty) industry. Under the Lynch model Amazon passes the P/E/Growth ratio, sales-to-P/E, EPS growth rate and total debt/equity tests, indicating attractive valuation versus growth and manageable leverage under these criteria. Free cash flow and net cash position are rated neutral, which moderates the positive signals by flagging potential constraints in cash conversion or liquidity. Associated metadata shows moderately positive sentiment (0.5) and a low market impact score (0.3), implying the report is constructive but unlikely to be a major market mover. Investors should treat the Validea rating as a favorable validation for growth-at-a-reasonable-price allocations while actively monitoring upcoming FCF and liquidity disclosures as the primary catalysts or risk triggers.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment